Genomics

Dataset Information

NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling


ABSTRACT: NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling

PROVIDER: PRJNA911143 | ENA |

REPOSITORIES: ENA